LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers ...
Read more
LONDON (Reuters) - Is nanomedicine the next big thing? A growing number of top drug companies seem to think so.The ability to encapsulate potent drugs in tiny particles measuring billionths ...
Read more
LONDON (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favoring the two U.S. companies.The ...
Read more
LONDON (Reuters) - Governments on both sides of the Atlantic are placing big new bets on the future of brain science, just as much of the pharmaceutical industry retreats from ...
Read more
LONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to ...
Read more
LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should greatly increase production capacity and ...
Read more
LONDON (Reuters) - Europe's financial crisis is costing lives, with suicides and infectious diseases on the rise, yet politicians are not addressing the problem, health experts said on Wednesday. Deep ...
Read more
LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to ...
Read more
February 20, 2013 9:16 am by Hirschler, Ben | 0 Comments
LONDON (Reuters) - One year on from a breast implant scandal that shook confidence in Europe's light-touch system for regulating medical devices, lawmakers and manufacturers are at loggerheads on ways ...
Read more
February 19, 2013 7:01 pm by Hirschler, Ben | 0 Comments
LONDON (Reuters) - In an unlikely tie-up, astronomers and cancer researchers have joined forces to study breast tumors using image analysis software originally developed to explore the distant stars.The automated ...
Read more
DAVOS, Switzerland (Reuters) - Novartis Chief Executive Joe Jimenez played down talk that it was looking to sell its one-third voting stake in crosstown rival Roche, and certainly not at ...
Read more
December 31, 2012 3:50 pm by Hirschler, Ben | 0 Comments
LONDON/NEW YORK (Reuters) - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars ...
Read more
December 18, 2012 12:20 pm by Hirschler, Ben | 0 Comments
LONDON (Reuters) - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs ...
Read more
December 17, 2012 8:43 am by Hirschler, Ben | 0 Comments
LONDON/PARIS (Reuters) - France's Vivalis and Austrian vaccine specialist Intercell are linking up in a rare cross-border deal that shows the need for Europe's fledgling biotech companies to grow in ...
Read more
November 22, 2012 11:04 am by Hirschler, Ben | 0 Comments
LONDON (Reuters) - Roche has offered an olive branch to scientific critics in a bid to end a bitter row over blockbuster flu drug Tamiflu that has led to calls ...
Read more
